INC Research Holdings Inc (INCR) Stock Rating Reaffirmed by Jefferies Group LLC

INC Research Holdings Inc (NASDAQ:INCR)‘s stock had its “buy” rating reissued by stock analysts at Jefferies Group LLC in a research report issued to clients and investors on Friday. They presently have a $51.00 price objective on the stock. Jefferies Group LLC’s price objective would indicate a potential upside of 16.04% from the company’s previous close.

Other research analysts also recently issued research reports about the company. TheStreet upgraded INC Research Holdings from a “c” rating to a “b-” rating in a report on Monday. Goldman Sachs Group Inc downgraded INC Research Holdings from a “conviction-buy” rating to a “buy” rating and set a $51.00 price target on the stock. in a report on Wednesday, March 1st. Zacks Investment Research upgraded INC Research Holdings from a “hold” rating to a “buy” rating and set a $59.00 price target on the stock in a report on Friday, January 6th. SunTrust Banks, Inc. downgraded INC Research Holdings from a “buy” rating to a “hold” rating and set a $48.00 price target on the stock. in a report on Monday, March 20th. Finally, William Blair reiterated an “outperform” rating on shares of INC Research Holdings in a report on Wednesday, March 1st. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $52.86.

Analyst Recommendations for INC Research Holdings (NASDAQ:INCR)

INC Research Holdings (NASDAQ:INCR) traded down 0.45% during mid-day trading on Friday, reaching $43.95. The company’s stock had a trading volume of 528,915 shares. INC Research Holdings has a 1-year low of $36.70 and a 1-year high of $56.88. The firm has a 50 day moving average price of $44.52 and a 200-day moving average price of $48.58. The company has a market capitalization of $2.37 billion, a PE ratio of 21.65 and a beta of 1.74.

INC Research Holdings (NASDAQ:INCR) last issued its quarterly earnings results on Tuesday, February 28th. The company reported $0.67 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.67. INC Research Holdings had a return on equity of 49.42% and a net margin of 6.58%. The business had revenue of $263 million for the quarter, compared to the consensus estimate of $269 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. INC Research Holdings’s revenue for the quarter was up 8.9% compared to the same quarter last year. On average, equities analysts predict that INC Research Holdings will post $2.66 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “INC Research Holdings Inc (INCR) Stock Rating Reaffirmed by Jefferies Group LLC” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://sportsperspectives.com/2017/04/21/inc-research-holdings-inc-incr-stock-rating-reaffirmed-by-jefferies-group-llc.html.

In other INC Research Holdings news, CAO Christopher L. Gaenzle sold 4,733 shares of the business’s stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $45.70, for a total value of $216,298.10. Following the completion of the sale, the chief accounting officer now owns 53,050 shares of the company’s stock, valued at $2,424,385. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Alistair Macdonald sold 8,828 shares of the business’s stock in a transaction dated Friday, March 3rd. The stock was sold at an average price of $45.00, for a total value of $397,260.00. Following the completion of the sale, the chief executive officer now directly owns 83,296 shares of the company’s stock, valued at approximately $3,748,320. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Several hedge funds have recently made changes to their positions in the company. UBS Asset Management Americas Inc. boosted its stake in shares of INC Research Holdings by 39.8% in the third quarter. UBS Asset Management Americas Inc. now owns 30,081 shares of the company’s stock worth $1,341,000 after buying an additional 8,560 shares in the last quarter. Buffington Mohr McNeal bought a new stake in shares of INC Research Holdings during the third quarter worth $2,545,000. Bank of New York Mellon Corp boosted its stake in shares of INC Research Holdings by 9.2% in the third quarter. Bank of New York Mellon Corp now owns 271,550 shares of the company’s stock worth $12,105,000 after buying an additional 22,918 shares in the last quarter. DUPONT CAPITAL MANAGEMENT Corp boosted its stake in shares of INC Research Holdings by 62.1% in the third quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 59,285 shares of the company’s stock worth $2,643,000 after buying an additional 22,715 shares in the last quarter. Finally, National Investment Services Inc. WI bought a new stake in shares of INC Research Holdings during the third quarter worth $244,000. 99.79% of the stock is owned by institutional investors.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

5 Day Chart for NASDAQ:INCR

Receive News & Ratings for INC Research Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply